Cosmeceutical skincare company SkinCeuticals has added the Phyto Corrective Masque to its ‘Correct’ collection.
Global skincare brand Medik8 has launched a new retinol product aimed at treating ageing skin without causing irritation.
Global pharmaceutical company LEO Pharma claims it has launched the first fixed-combination foam spray for the treatment of plaque psoriasis in the UK.
An FDA-assembled panel has approved brodalumab for adult patients with moderate-to-severe plaque psoriasis.
Clinic representatives and aesthetic practitioners gathered at Home House in London for the SculpSure Meet the Expert event on June 15.
The US Food and Drug Administration (FDA) has approved Allergan to market JUVÉDERM VOLBELLA XC for lip augmentation and to correct perioral rhytides in adults over the age of 21.
An investigational topical prescription product for the treatment of persistent facial erythema associated with rosacea in adults has been accepted by the Food and Drug Administration (FDA) for standard review.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Bocouture, a botulinum neurotoxin type A treatment, in the UK for treatment of upper facial lines.
Results of a new study indicate that Botox (onabotulinumtoxinA, Allergan) can be used to treat crow’s feet lines safely and effectively.
A new study published in Dermatologic Surgery in April suggests platelet-rich plasma (PRP) has a positive effect on androgenetic alopecia (AGA).